1. Home
  2. HDSN vs SLN Comparison

HDSN vs SLN Comparison

Compare HDSN & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudson Technologies Inc.

HDSN

Hudson Technologies Inc.

HOLD

Current Price

$7.31

Market Cap

409.2M

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$6.96

Market Cap

318.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HDSN
SLN
Founded
1991
1994
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
409.2M
318.4M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
HDSN
SLN
Price
$7.31
$6.96
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$9.50
$39.67
AVG Volume (30 Days)
524.0K
280.4K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.50
N/A
Revenue
$236,847,000.00
$25,830,000.00
Revenue This Year
$2.65
N/A
Revenue Next Year
$3.69
N/A
P/E Ratio
$14.55
N/A
Revenue Growth
N/A
40.39
52 Week Low
$5.11
$1.97
52 Week High
$10.52
$8.88

Technical Indicators

Market Signals
Indicator
HDSN
SLN
Relative Strength Index (RSI) 46.12 56.90
Support Level $6.53 $5.98
Resistance Level $7.74 $6.88
Average True Range (ATR) 0.27 0.52
MACD 0.17 0.02
Stochastic Oscillator 63.64 71.63

Price Performance

Historical Comparison
HDSN
SLN

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: